Pathogenic C difficile is here (and everywhere) to stay

The Lancet

Volumn 377, Issue 9759, 2011, Pages 8-9

  Warren, Cirle A ^a   Guerrant, Richard L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE INFECTION; HUMAN; INFECTION RATE; INFECTION RISK; MOLECULAR TYPING; NOTE; PRIORITY JOURNAL;

EID: 78650827016     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61885-5     Document Type: Note

References (15)

1. MP Bauer, DW Notermans, BHB van Benthem for the ECDIS Study Group Clostridium difficile infection in Europe: a hospital-based survey Lancet 2010 10.1016/S0140-6736(10)61266-4 published online Nov 16.
2. M Rupnik, MH Wilcox, DN Gerding Clostridium difficile infection: new developments in epidemiology and pathogenesis Nat Rev Microbiol 7 2009 526 536
3. M Rupnik Clostridium difficile toxinotypes http://www.mf.uni-mb.si/mikro/ tox August, 2010 (accessed Sept 13, 2010).
4. T Akerlund, I Persson, M Unemo Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1 J Clin Microbiol 46 2008 1530 1533
5. LC McDonald, GE Killgore, A Thompson An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 2005 2433 2441
6. J Cloud, L Noddin, A Pressman, M Hu, C Kelly Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting Clin Gastroenterol Hepatol 7 2009 868 873
7. V Wilson, L Cheek, G Satta Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom Clin Infect Dis 50 2010 e77 e81
8. SW Pawlowski, L Archbald-Pannone, RJ Carman Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C difficile J Hosp Infect 73 2009 185 187
9. JG Bartlett, TW Chang, M Gurwith, SL Gorbach, AB Onderdonk Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia N Engl J Med 298 1978 531 534
10. L Archbald-Pannone, C Alcantara-Warren, J Lyman, RL Guerrant Fluoroquinolone use and increased incidence of C difficile associated diarrhea UVA J Med 6 2009 45 48
11. CA Muto, M Pokrywka, K Shutt A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use Infect Control Hosp Epidemiol 26 2005 273 280
12. SP Borriello The influence of the normal flora on Clostridium difficile colonisation of the gut Ann Med 22 1990 61 67
13. Centers for Disease Control and Prevention (CDC) Surveillance for community-associated Clostridium difficile - Connecticut, 2006 MMWR Morb Mortal Wkly Rep 57 2008 340 343
14. D Bakker, J Corver, C Harmanus Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates based on multilocus variable-number tandem-repeat analysis and tetracycline resistance J Clin Microbiol 48 2010 3744 3749
15. MA Jhung, AD Thompson, GE Killgore Toxinotype V Clostridium difficile in humans and food animals Emerg Infect Dis 14 2008 1039 1045